A Spanish Multicenter, Cross-sectional, Observational Study to Evaluate the Effectiveness of Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects in Daily Clinical Practice (SOMACROL).

Trial Profile

A Spanish Multicenter, Cross-sectional, Observational Study to Evaluate the Effectiveness of Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects in Daily Clinical Practice (SOMACROL).

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Jul 2017

At a glance

  • Drugs Lanreotide (Primary)
  • Indications Acromegaly
  • Focus Therapeutic Use
  • Acronyms SOMACROL
  • Sponsors Ipsen
  • Most Recent Events

    • 25 Jul 2017 Planned number of patients changed from 150 to 100.
    • 25 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
    • 25 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top